Clinical Trial Update: Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating simvastatin as a neuroprotective treatment for moderate Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University Hospital Plymouth NHS Trust | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED